cognitive cybersecurity intelligence

News and Analysis


Galera Expands Commercial Leadership Team

Company appoints leading sales, market access and operations executives with decades of experience successfully launching and commercializing new oncology products
New Drug Application (NDA) for avasopasem is currently under priority review by the U.S. Food and Drug Administration (FDA) with a…

Source: www.marketscreener.comRead more

Subscribe to newsletter

Subscribe to HEAL Security Dispatch for the latest healthcare cybersecurity news and analysis.

More Posts